Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies
Crossref DOI link: https://doi.org/10.1007/s40266-016-0382-1
Published Online: 2016-06-29
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fioretto, Paola
Mansfield, Traci A.
Ptaszynska, Agata
Yavin, Yshai
Johnsson, Eva
Parikh, Shamik
Funding for this research was provided by:
AstraZeneca
License valid from 2016-06-29